Search

everythinglearnresearchcommunity

for

Search:↓

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Many transgender men on testosterone therapy experience hair loss.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Feminizing hormone therapy increases kidney filtration rate.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Testosterone treatment may affect heart response to stress in transgender men.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.